~~<i id='F918305856'><strike id='F918305856'><tt id='F918305856'><pre id='F918305856'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

author：entertainment 2025-10-06 14:48:19 Page View：48556

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Researchers on aging grapple with how to calculate biological age
Next article： The cancer drug shortage isn’t new — and neither are the solutions

comprehensive

How one medical school became remarkably diverse

ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

DanSkovronsky,EliLilly'schiefscientificofficer,atthe2023STATSummit.STATPHILADELPHIA—Inasense,theannu

23andMe had bad news about my health. I wish a person had delivered it

ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

Researchers on aging grapple with how to calculate biological age

AdobeIt’snosecretthataluckyfewseemtoglideintooldage,theyearssettlinggracefullyontheirbodies,whileoth